- Release Date: 02/12/24 09:12
- Summary: Outstanding Remplir Study Results Pave Way for FDA Clearance
- Price Sensitive: Yes
- Download Document 246.68KB
Ann: Outstanding Remplir Study Results Pave Way for FDA Clearance
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.15 | $1.14 | $91.18K | 79.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4362 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 30092 | 8 |
View Market Depth
| Last trade - 14.52pm 10/09/2025 (20 minute delay) ? |
| OCC (ASX) Chart |